Skip to the main content
Open WellbeingWhat the studies actually measured

Blood sugar and insulin

N-acetylcysteineand Fasting insulin

Both sources here found no clear difference in fasting insulin.

How sure anyone can be

Low certainty, level 2 of 4

Further research is likely to change this.

The most certain of the two findings here; each record carries its own.

The numbers reported

One source’s range, drawn against its own line of no difference and scaled to its own numbers.

-0.53-0.24 standardised effect size0.06

This range crosses the no-difference line, so these numbers fit a real difference and no difference at all equally well.

Bar the confidence interval — the range the true effect is likely to sit inNotch the number the source reportedLine where there would be no difference at all

Two sources, newest first

What we read is the published abstract, not the full paper, so a blank below may still be printed in the paper itself. A fixed rule worked this out from the source’s own fields. Nobody checked this rating by hand.

  • Randomised trial, 2026

    Low certainty, level 2 of 4

    Effect of high dose N-acetyl cysteine supplementation on markers of oxidative stress and insulin resistance in non-diabetic patients with metabolic dysfunction associated steatotic liver disease: a randomized controlled trial.

    BMC Gastroenterol. 2026;26(1). doi:10.1186/s12876-026-05157-x. PMID:42587287.

    Number reported
    Not in the abstract
    Which way it went
    No clear difference
    Likely range
    Not in the abstract
    Source’s own words
    fasting insulin vs lifestyle intervention alone; no significant between-group difference; magnitude not given
    Who was studied
    Non diabetic adults with MASLD
    Compared with
    lifestyle intervention alone
    Amount taken
    2,400 mg/day
    For how long
    Not in the abstract
    Disagreement between studies
    Not in the abstract
    Kind of record
    Journal article
    How this rating was reachedstarts at High, 2 steps down: risk of bias and imprecision
    1. Starts at High
    2. Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
    3. Imprecision brought it down to Lowthe abstract reports no confidence interval for the estimateNot in the abstract
    4. Ends at Low2 steps down.
    Checked, nothing to step it down for
    indirectness
    Inconsistency
    One study, so there was nothing to disagree

    Imprecision stops at the first check that applies; others may apply too.

    Source saved; quote checked byte-for-byte against it by software; no signature.

    Read the abstract on PubMed

  • Systematic review, 2023

    Low certainty, level 2 of 4

    The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis.

    Front Nutr. 2023;10:1209614. doi:10.3389/fnut.2023.1209614. PMID:37841396.

    Number reported
    -0.24 standardised effect size
    Which way it went
    No clear difference
    Likely range
    -0.53 to 0.06
    Source’s own words
    standardised mean difference in fasting insulin vs metformin
    Who was studied
    Adult with PCOS
    Compared with
    metformin
    Amount taken
    Not in the abstract
    For how long
    Not in the abstract
    Disagreement between studies
    Not in the abstract
    Kind of record
    Journal article
    How this rating was reachedstarts at High, 2 steps down: risk of bias and imprecision
    1. Starts at High
    2. Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
    3. Imprecision brought it down to Lowthe confidence interval includes no effectReported in the abstract
    4. Ends at Low2 steps down.
    Checked, nothing to step it down for
    indirectness
    Inconsistency
    No disagreement reported, and no count of studies behind it

    Imprecision stops at the first check that applies; others may apply too.

    AI-reviewed & signed — an AI agent re-read this finding against the saved source and checked that the quote, the numbers, the units and the direction match it. No person read it. The owner authorised the agent to sign the batch with the owner's key, and every build rechecks that signature against these exact bytes.

    Read the abstract on PubMed

What is still missing from these readings

  • One give no number at all, only which way it went.
  • One gives no likely range, so how precise that number is is unknown.
  • Two do not say how many people took part.
  • Amount taken — One of Two readings: Not in the abstract.
  • For how long — Not in the abstract.

Something nobody wrote down is never a zero and never a guess.

Still to read for N-acetylcysteine

Seven of the 18 things on our list for N-acetylcysteine have no reading here yet:

  • Alanine aminotransferase (ALT)
  • Aspartate aminotransferase (AST)
  • Cycling Functional Threshold Power
  • Cycling Power
  • Diastolic blood pressure
  • HOMA-IR
  • Systolic blood pressure

Still to read means nobody here has got to it, not that it was tried and did nothing or that no research exists. A pairing on no list is not a gap: we never set out to read it.

Read next

This is a library, not advice. No recommendation, no dose, no diagnosis, no ranking. We never ask about your symptoms, and nothing here is tailored to you.